[1]
Y. Mohammadi-Kebar, H. Zandian, and Z. Khazdooz, “The impact of anti-tumor necrosis factor alpha drugs on lipid profile of patients with rheumatoid arthritis or seronegative spondyloarthropathy”, Int J Basic Clin Pharmacol, vol. 13, no. 1, pp. 47–50, Dec. 2023.